Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Sales | 41,636 | 40,198 | 29,211 | 18,821 | 11,059 |
| Cost of Goods | 4,773 | 5,211 | 3,096 | 2,594 | 1,764 |
| Gross Profit | 36,863 | 34,987 | 26,115 | 16,227 | 9,295 |
| Operating Expenses | 24,967 | 20,782 | 14,076 | 11,633 | 9,239 |
| Operating Income | 12,669 | 14,416 | 12,135 | 5,188 | 820 |
| Interest Expense | 0 | 5 | 0 | 272 | 673 |
| Other Income | 19 | -18 | -16 | 6 | -4 |
| Pre-tax Income | 12,688 | 14,393 | 12,119 | 4,922 | 143 |
| Income Tax | 5,030 | -9,707 | 532 | 375 | N/A |
| Net Income Continuous | 7,658 | 24,100 | 11,587 | 4,547 | 143 |
| Net Income | $7,658 | $24,100 | $11,587 | $4,547 | $143 |
| EPS Basic Total Ops | 0.12 | 0.51 | 0.18 | 0.09 | 0.01 |
| EPS Basic Continuous Ops | 0.11 | 0.50 | 0.18 | 0.09 | 0.01 |
| EPS Diluted Total Ops | 0.11 | 0.44 | 0.17 | 0.09 | 0.01 |
| EPS Diluted Continuous Ops | 0.10 | 0.44 | 0.17 | 0.09 | 0.00 |
| EBITDA(a) | $13,192 | $14,893 | $12,581 | $5,624 | $1,249 |